OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2020
(2)
2022
(1)
2021
(1)
2019
(1)
2018
(1)
2017
(1)
2006
(1)
2004
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
CHEK2 is a multiorgan cancer susceptibility gene.
Not available
S-EPMC1182149
|
biostudies-literature
Cite
Low-risk Genes and Multi-organ Cancer Risk in the Polish Population.
Not available
S-EPMC3401922
|
biostudies-literature
Cite
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Not available
S-EPMC9276789
|
biostudies-literature
Cite
Survival from breast cancer in women with a BRCA2 mutation by treatment.
Not available
S-EPMC8076275
|
biostudies-literature
Cite
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
Not available
S-EPMC8207534
|
biostudies-literature
Cite
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
Not available
S-EPMC5744673
|
biostudies-literature
Cite
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Not available
S-EPMC7572656
|
biostudies-literature
Cite
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Not available
S-EPMC5870793
|
biostudies-literature
Cite
Prognostic gene expression signature for high-grade serous ovarian cancer.
Not available
S-EPMC7484370
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets